This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Christiphe Denis Pascal Adelinet: Innovator in Pharmaceutical Compounds
Introduction
Christiphe Denis Pascal Adelinet is a notable inventor based in Issy-les-Moulineaux, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. His work is crucial in the ongoing fight against diseases such as cancer.
Latest Patents
Adelinet holds a patent for "Cyclin-dependent kinase 7 (CDK7) non-covalent inhibitors." This invention relates to pharmaceutical compounds of formula (I) and pharmaceutical compositions that comprise these compounds. The patent outlines processes for the preparation of these compounds and their use as inhibitors of cyclin-dependent kinase 7 (CDK7). This innovation has potential applications in the treatment of various diseases, including cancer.
Career Highlights
Christiphe Denis Pascal Adelinet is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His role at the company allows him to further his research and development efforts in creating effective therapeutic solutions.
Collaborations
Adelinet collaborates with various professionals in his field, including his coworker Sophie Coupa Ép Descamps. Their combined expertise contributes to the advancement of innovative pharmaceutical solutions.
Conclusion
Christiphe Denis Pascal Adelinet is a prominent figure in the pharmaceutical industry, recognized for his innovative work on CDK7 inhibitors. His contributions are vital in the development of new treatments for serious diseases, showcasing the importance of research and innovation in healthcare.